The Nacimbio Holding Company of the Rostec State Corporation encompasses biopharmaceutical enterprises specialising in development, production, and marketing of biological drug products, and organises the vaccine supply within all Russian regions.
The “Best Technical Director” competition is held within the framework of the VI All-Russian GMP Conference with International Participation, which will take place on September 22-24, 2021 in a hybrid format and consists of two stages.
The VI All-Russian GMP Conference with International Participation to be held on September 22-24, 2021 in a hybrid format will become one of the key events of the year in the sphere of good practices. This year, the general partner of the Conference is Nacimbio JSC.
Gedeon Richter, a partner of the VI All-Russian GMP Conference with International Participation, is present in more than 100 countries around the world and has unique expertise in the implementation and development of a quality system.
MSD, a partner of the VI All-Russian GMP Conference with International Participation, has been one of the leading international companies in the healthcare sector for over 125 years. Its focuses on development and production of innovative medicines and vaccines, clinical trials, and partnerships in pharmaceutical manufacturing. The company started its operation in our country in […]
Novartis is an international pharmaceutical company headquartered in Basel, Switzerland. The company’s subdivisions, factories and research centres are located in different countries throughout the world and incorporate more than 110 thousand employees – representatives of 142 nationalities.
AKRIKHIN is one of the leading Russian pharmaceutical companies producing high-quality medicines of therapeutic groups most demanded in Russia: dermatology, cardiology, neurology, gynaecology, pulmonology, endocrinology, and others.
In 2019, Czech Republic’s leading pharmaceutical company PRO.MED.CS Praha a.s. celebrated its 30th anniversary. Today, this manufacturer supplies products to more than 25 countries, primarily, to the Russian Federation, Central and Eastern Europe, and Central Asia.
At the session held on 22 September as part of the VI All-Russian GMP Conference with International Participation, speakers will discuss the role of good pharmaceutical practices in the context of an efficient regulatory framework covering medicines life cycle of in Russia and the EAEU.